IPO Timeline
Broker Results (T-2)
2022-12-21
Some brokers release in afternoon
Grey Market (T-1)
2022-12-22
Afternoon
HKEX Allotment (T-1)
2022-12-22
Evening
Registrar Allotment (T-1)
2022-12-22
Evening
Listing Day (T)
2022-12-23
First day of trading
Company Overview
| Stock Name | 业聚医疗 |
|---|---|
| Stock Code | 06929 |
| Company Full Name | 业聚医疗 |
| Industry | 醫療保健 |
| Principal Activities | 主要從事設計、開發、制造及銷售用於治療冠狀動脈及外周血管疾病的醫療器械。 |
| Listing Date | 2022-12-23 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港新界沙田香港科學園20E號樓3樓303室和305室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://orbusneich.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 8.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 65.3% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 48,083,200 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 4,400 |
| 2 lots | 1,000 | HK$ 8,800 |
| 3 lots | 1,500 | HK$ 13,200 |
| 4 lots | 2,000 | HK$ 17,600 |
| 5 lots | 2,500 | HK$ 22,000 |
| 6 lots | 3,000 | HK$ 26,400 |
| 7 lots | 3,500 | HK$ 30,800 |
| 8 lots | 4,000 | HK$ 35,200 |
| 9 lots | 4,500 | HK$ 39,600 |
| 10 lots | 5,000 | HK$ 44,000 |
| 12 lots | 6,000 | HK$ 52,800 |
| 14 lots | 7,000 | HK$ 61,600 |
| 16 lots | 8,000 | HK$ 70,400 |
| 18 lots | 9,000 | HK$ 79,200 |
| 20 lots | 10,000 | HK$ 88,000 |
| 30 lots | 15,000 | HK$ 132,000 |
| 40 lots | 20,000 | HK$ 176,000 |
| 50 lots | 25,000 | HK$ 220,000 |
| 60 lots | 30,000 | HK$ 264,000 |
| 70 lots | 35,000 | HK$ 308,000 |
| 80 lots | 40,000 | HK$ 352,000 |
| 90 lots | 45,000 | HK$ 396,000 |
| 100 lots | 50,000 | HK$ 440,000 |
| 120 lots | 60,000 | HK$ 528,000 |
| 140 lots | 70,000 | HK$ 616,000 |
| 160 lots | 80,000 | HK$ 704,000 |
| 180 lots | 90,000 | HK$ 792,000 |
| 200 lots | 100,000 | HK$ 880,000 |
| 400 lots | 200,000 | HK$ 1,760,000 |
| 500 lots | 250,000 | HK$ 2,200,000 |
| 800 lots | 400,000 | HK$ 3,520,000 |
| 1,000 lots | 500,000 | HK$ 4,400,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1,200 lots | 600,000 | HK$ 5,280,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 9.15 |
|---|---|
| First Day Open | HK$ 8.8 |
| First Day Change | 3.98% |
| First Day Volume | 4592500.0 |
| First Day Turnover | 40174300.0 |
Use of Proceeds
| Use of Proceeds | 1、30.0%（或約110.0百萬港元）分配予在研產品開發及商業化； 2、54.2%（或約198.8百萬港元）被分配用于擴大我們的產能； 3、10.8%（或約39.7百萬港元）用于為潛在戰略收購、建立戰略合作伙伴關系及其他業務發展提供資金； 4、5.0%（或約18.3百萬港元）用作營運資金及用于其他一般企業事項。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894
建银国际金融有限公司 CE AJO225
Overall Coordinators (5)
中国国际金融香港证券有限公司 CE AEN894
建银国际金融有限公司 CE AJO225
法国巴黎证券（亚洲）有限公司 CE AAF669
中信里昂证券有限公司 CE AAB893
招商证券（香港）有限公司 CE AAI650
Joint Bookrunners (8)
中国国际金融香港证券有限公司 CE AEN894
建银国际金融有限公司 CE AJO225
法国巴黎证券（亚洲）有限公司 CE AAF669
中信里昂证券有限公司 CE AAB893
招商证券（香港）有限公司 CE AAI650
ZMF Asset Management Limited CE AWF641
富途证券国际（香港）有限公司 CE AZT137
越秀证券有限公司 CE ABQ722
Joint Lead Managers (8)
中国国际金融香港证券有限公司 CE AEN894
建银国际金融有限公司 CE AJO225
法国巴黎证券（亚洲）有限公司 CE AAF669
中信里昂证券有限公司 CE AAB893
招商证券（香港）有限公司 CE AAI650
ZMF Asset Management Limited CE AWF641
富途证券国际（香港）有限公司 CE AZT137
越秀证券有限公司 CE ABQ722
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 杭州富阳产业基金投资管理有限公司 | 313,997,200 HKD | — | 65.31% | — | 6 months | 2023-06-23 |
Directors & Management
| Chairman | 錢永勛 |
|---|---|
| Company Secretary | 陳泳成 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 錢永勛及家族成員(63.00%);深圳市創新投資集團有限公司(11.84%) |
|---|
Subscription Tiers
IPO Timeline
